文献速递免疫规划

流感疫苗临床免疫原性评价进展

Advances in clinical immunogenicity evaluation of influenza vaccines.
PubMed 文献 · Vaccine · 2026-08-03

本文系统梳理流感疫苗免疫原性评价方法,涵盖血凝抑制试验、微量中和试验、ELISA、黏膜分泌型IgA检测、酶联免疫斑点及流式细胞术等多维框架,并强调临床攻击试验对阐明免疫原性与保护效力关系的作用,旨在为疫苗研发与评价建立系统参考。

要点

  • 流感疫苗免疫原性评价需兼顾体液、细胞与黏膜免疫多维框架。
  • 血凝抑制、微量中和、ELISA、黏膜sIgA、ELISpot和流式细胞术各有优劣。
  • 临床攻击试验对阐明免疫原性与保护效力关系具有重要作用。

核心结论

  • 流感疫苗免疫原性评价方法日趋多样复杂,需建立系统综合评价框架以推进疫苗设计与保护结局预测的精准化。

研究设计与样本

  • 本文为综述,系统分析裂解病毒颗粒、亚单位、重组蛋白和减毒活流感疫苗等多种剂型的免疫原性评价方法的优势与局限。

主要发现

  • 评价框架覆盖体液免疫、细胞免疫和黏膜免疫三个维度。
  • 涉及的分析技术包括血凝抑制试验、微量中和试验、酶联免疫吸附试验、黏膜分泌型IgA检测、酶联免疫斑点试验和流式细胞术。
  • 临床攻击试验在阐明免疫原性与保护效力关系方面发挥重要作用。

临床怎么用

  • 可为流感疫苗研发中的免疫原性评价选择合适方法组合提供参考,并支持保护结局的精准预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza vaccination is an effective intervention for preventing severe influenza, and assessing its immunogenicity is a critical step in determining vaccine protective efficacy. With the widespread use of influenza vaccines-including split-virion, subunit, recombinant protein, and live attenuated formulations-methods for evaluating immunogenicity have grown increasingly diverse and complex. This article systematically examines the advantages and limitations of various immunogenicity assessment approaches for influenza vaccines. It draws upon multidimensional evaluation frameworks covering humoral, cellular, and mucosal immunity, incorporating analytical techniques such as hemagglutination inhibition assays, microneutralization assays, enzyme-linked immunosorbent assays, mucosal secretory IgA detection, enzyme-linked immunospot assays, and flow cytometry. Furthermore, clinical challenge trials evaluations play an essential role in elucidating the relationship between immunogenicity and protective efficacy. This paper aims to establish a systematic and comprehensive reference framework for the development and immunogenicity evaluation of influenza vaccines, thereby advancing vaccine design and the prediction of protective outcomes toward greater precision.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Xu N, Wang L, Zhao C, et al. Advances in clinical immunogenicity evaluation of influenza vaccines. Vaccine. 2026. PMID: 42546636. doi:10.1016/j.vaccine.2026.128989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。